Anavex Life Sciences Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$43,002,000 over the previous period. Total operating expenses were $52,877,000.
Profit Margin
| 2015 | 0 | -12.10M | |
|---|---|---|---|
| 2016 | 0 | -14.73M | |
| 2017 | 0 | -13.46M | |
| 2018 | 0 | -17.45M | |
| 2019 | 0 | -26.29M | |
| 2020 | 0 | -26.28M | |
| 2021 | 0 | -37.90M | |
| 2022 | 0 | -47.97M | |
| 2023 | 0 | -47.50M | |
| 2024 | 0 | -43.00M |
AVXL Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 41.83M | 43.71M | 37.91M | 32.98M | 25.23M | 22.26M | 13.34M | 10.67M | 7.25M | 2.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 52.87M | 55.75M | 50.98M | 41.94M | 30.93M | 28.80M | 19.18M | 15.53M | 14.87M | 7.10M |
Operating income | 0 | -55.75M | -54.39M | -41.92M | -30.75M | -28.75M | -19.18M | -15.53M | -14.87M | -7.10M |
Other income (expenses), net | 0 | 8.25M | 6.77M | 4.27M | 4.83M | 2.53M | 1.57M | 2.27M | 164.16K | -4.99M |
Income before tax | -43.00M | -47.49M | -47.61M | -37.64M | -26.25M | -26.21M | -17.38M | -13.40M | -14.70M | -12.10M |
Income tax expense | 0 | 7K | 358.49K | 267.56K | 22.66K | 82.18K | 72.74K | 59.60K | 29.61K | 71.82K |
Net income | -43.00M | -47.50M | -47.97M | -37.90M | -26.28M | -26.29M | -17.45M | -13.46M | -14.73M | -12.10M |
Earnings per share | ||||||||||
Basic EPS | -0.52 | -0.6 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 | -0.33 | -0.42 | -0.65 |
Diluted EPS | -0.52 | -0.6 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 | -0.33 | -0.42 | -0.65 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |